(by Doug Bean | LifeSite News) – An attorney recently released data showing a remarkably high fatality rate for COVID patients who were prescribed Remdesivir. According to attorney Thomas Renz, 25.9% of those prescribed Remdesivir for COVID-19 are recorded as having died in the Centers for Medicare & Medicaid Services (CMS) database. CMS data indicated that of 7,960 beneficiaries prescribed Remdesivir for COVID‐19, 2,058 beneficiaries died. Forty-six percent of those fatalities occurred within 14 days of Remdesivir treatment. The death rate for COVID patients prescribed Remdesivir dwarfs the fatality rate of COVID patients prescribed Ivermectin, which is recorded by the CMS database as being 7.2%. For the public’s further consideration of Remdesivir’s […]

This post was originally published on this site